Hypoxia and therapeutic treatment of EV-A71 with an immune modulator TLR7 agonist in a new immunocompetent mouse model

[1]  S. Gau,et al.  Enterovirus A71 neurologic complications and long-term sequelae , 2019, Journal of Biomedical Science.

[2]  Ya-Ting Chang,et al.  Enterovirus 71 targets the cardiopulmonary system in a robust oral infection mouse model , 2019, Scientific Reports.

[3]  N. Petrovsky,et al.  Mitochondrial haplogroups are not associated with diabetic retinopathy in a large Australian and British Caucasian sample , 2019, Scientific Reports.

[4]  G. D. da Rocha,et al.  Occurrence of the potent mutagens 2- nitrobenzanthrone and 3-nitrobenzanthrone in fine airborne particles , 2019, Scientific Reports.

[5]  Chun-Che Liao,et al.  Immunocompetent and Immunodeficient Mouse Models for Enterovirus 71 Pathogenesis and Therapy , 2018, Viruses.

[6]  J. Strating,et al.  The life cycle of non-polio enteroviruses and how to target it , 2018, Nature Reviews Microbiology.

[7]  C. Qin,et al.  GS‐9620 inhibits enterovirus 71 replication mainly through the NF‐&kgr;B and PI3K‐AKT signaling pathways , 2018, Antiviral research.

[8]  C. Shih,et al.  Hepatitis B Virus. , 2018, Trends in microbiology.

[9]  Huan-guo Li,et al.  The pulmonary complications associated with EV71-infected hand–foot–mouth disease , 2017 .

[10]  L. Ng,et al.  Immunopathogenesis and Virus–Host Interactions of Enterovirus 71 in Patients with Hand, Foot and Mouth Disease , 2017, Front. Microbiol..

[11]  J. Kwang,et al.  Effective in vivo therapeutic IgG antibody against VP3 of enterovirus 71 with receptor-competing activity , 2017, Scientific Reports.

[12]  A. Brault,et al.  Frequent Zika Virus Sexual Transmission and Prolonged Viral RNA Shedding in an Immunodeficient Mouse Model , 2017, Cell reports.

[13]  J. A. Regla-Nava,et al.  A Mouse Model of Zika Virus Sexual Transmission and Vaginal Viral Replication. , 2016, Cell reports.

[14]  A. Ridiandries,et al.  The Role of CC-Chemokines in the Regulation of Angiogenesis. , 2016, International journal of molecular sciences.

[15]  J. Chu,et al.  Single dose of an adenovirus vectored mouse interferon-α protects mice from lethal EV71 challenge , 2016, Antiviral Research.

[16]  Jyun-Yuan Huang,et al.  Control and Eradication Strategies of Hepatitis B Virus. , 2016, Trends in microbiology.

[17]  Hailong Lin,et al.  Efficacy and safety of interferon-α2b spray in the treatment of hand, foot, and mouth disease: a multicenter, randomized, double-blind trial , 2016, Archives of Virology.

[18]  Chun-Che Liao,et al.  A new animal model containing human SCARB2 and lacking stat-1 is highly susceptible to EV71 , 2016, Scientific Reports.

[19]  M. Arcangeletti,et al.  A cluster of Enterovirus 71 subgenogroup C2 in a nursery school, Italy, 2014. , 2016, The new microbiologica.

[20]  Guangdi Li,et al.  Approved Antiviral Drugs over the Past 50 Years , 2016, Clinical Microbiology Reviews.

[21]  R. Tesh,et al.  Characterization of a Novel Murine Model to Study Zika Virus , 2016, The American journal of tropical medicine and hygiene.

[22]  E. Rankin,et al.  Hypoxic control of metastasis , 2016, Science.

[23]  Haiyan Wei,et al.  Clinical Efficacy of Therapy with Recombinant Human Interferon α1b in Hand, Foot, and Mouth Disease with Enterovirus 71 Infection , 2016, PloS one.

[24]  Javier Martin,et al.  Twenty-Eight Years of Poliovirus Replication in an Immunodeficient Individual: Impact on the Global Polio Eradication Initiative , 2015, PLoS pathogens.

[25]  C. Coffin,et al.  The oral toll-like receptor-7 agonist GS-9620 in patients with chronic hepatitis B virus infection. , 2015, Journal of hepatology.

[26]  R. Hartmann,et al.  Guarding the frontiers: the biology of type III interferons , 2015, Nature Immunology.

[27]  Albert C. Huang,et al.  Interferon-λ restricts West Nile virus neuroinvasion by tightening the blood-brain barrier , 2015, Science Translational Medicine.

[28]  T. Walters,et al.  Therapeutic strategies for preventing skeletal muscle fibrosis after injury , 2015, Front. Pharmacol..

[29]  K. Tsao,et al.  Reemergence of Enterovirus 71 Epidemic in Northern Taiwan, 2012 , 2015, PloS one.

[30]  Hongjun Li,et al.  Neuroimaging of HFMD infected by EV71 , 2015 .

[31]  Y. Lo,et al.  Cell Surface Nucleolin Facilitates Enterovirus 71 Binding and Infection , 2015, Journal of Virology.

[32]  S. Midgley,et al.  Emergence of enterovirus 71 C4a in Denmark, 2009 to 2013. , 2014, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.

[33]  P. Tu,et al.  Immunodeficient Mouse Models with Different Disease Profiles by In Vivo Infection with the Same Clinical Isolate of Enterovirus 71 , 2014, Journal of Virology.

[34]  A. Lukashev,et al.  Seroepidemiology and Molecular Epidemiology of Enterovirus 71 in Russia , 2014, PloS one.

[35]  J. Kwang,et al.  Attenuation of Human Enterovirus 71 High-Replication-Fidelity Variants in AG129 Mice , 2014, Journal of Virology.

[36]  R. Nemenoff,et al.  Transmigrating neutrophils shape the mucosal microenvironment through localized oxygen depletion to influence resolution of inflammation. , 2014, Immunity.

[37]  K. Fujii,et al.  Transgenic mouse model for the study of enterovirus 71 neuropathogenesis , 2013, Proceedings of the National Academy of Sciences.

[38]  J. Schmid,et al.  The complexity of NF-κB signaling in inflammation and cancer , 2013, Molecular Cancer.

[39]  Yanfeng Xu,et al.  Necrotizing myositis causes restrictive hypoventilation in a mouse model for human enterovirus 71 infection , 2013, Virology Journal.

[40]  F. Hu,et al.  A pathogenic picornavirus acquires an envelope by hijacking cellular membranes , 2013, Nature.

[41]  P. Chong,et al.  Human SCARB2 Transgenic Mice as an Infectious Animal Model for Enterovirus 71 , 2013, PloS one.

[42]  K. Matsuura,et al.  MiR-29c is downregulated in gastric carcinomas and regulates cell proliferation by targeting RCC2 , 2013, Molecular Cancer.

[43]  Jia Jun Lee,et al.  A Non-Mouse-Adapted Enterovirus 71 (EV71) Strain Exhibits Neurotropism, Causing Neurological Manifestations in a Novel Mouse Model of EV71 Infection , 2011, Journal of Virology.

[44]  M. Ho,et al.  Annexin II Binds to Capsid Protein VP1 of Enterovirus 71 and Enhances Viral Infectivity , 2011, Journal of Virology.

[45]  T. Solomon,et al.  Clinical features, diagnosis, and management of enterovirus 71 , 2010, The Lancet Neurology.

[46]  Kuo-Feng Weng,et al.  Neural pathogenesis of enterovirus 71 infection. , 2010, Microbes and infection.

[47]  M. Shimojima,et al.  Human P-selectin glycoprotein ligand-1 is a functional receptor for enterovirus 71 , 2009, Nature Medicine.

[48]  S. Koike,et al.  Scavenger receptor B2 is a cellular receptor for enterovirus 71 , 2009, Nature Medicine.

[49]  S. Gau,et al.  Neurodevelopment and cognition in children after enterovirus 71 infection. , 2007, The New England journal of medicine.

[50]  V. Racaniello.  One hundred years of poliovirus pathogenesis. , 2006, Virology.

[51]  H. Lei,et al.  Type I interferons protect mice against enterovirus 71 infection. , 2005, The Journal of general virology.

[52]  J. Tidball.  Inflammatory processes in muscle injury and repair. , 2005, American journal of physiology. Regulatory, integrative and comparative physiology.

[53]  H. Lei,et al.  A Mouse-Adapted Enterovirus 71 Strain Causes Neurological Disease in Mice after Oral Infection , 2004, Journal of Virology.

[54]  A. Moscicki,et al.  External genital warts: diagnosis, treatment, and prevention. , 2002, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[55]  R. Detels,et al.  Validity of self-reporting of episodes of external genital warts. , 2002, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[56]  Kow-Tong Chen,et al.  An epidemic of enterovirus 71 infection in Taiwan. Taiwan Enterovirus Epidemic Working Group. , 1999, The New England journal of medicine.

[57]  K. Chua,et al.  Fatal enterovirus 71 encephalomyelitis. , 1998, The Journal of pediatrics.

[58]  S. Spruance,et al.  Treatment of genital warts with an immune-response modifier (imiquimod). , 1998, Journal of the American Academy of Dermatology.

[59]  W. Kaelin,et al.  Negative regulation of hypoxia-inducible genes by the von Hippel-Lindau protein. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[60]  M. Pallansch,et al.  Enterovirus 71 infections and neurologic disease--United States, 1977-1991. , 1994, The Journal of infectious diseases.

[61]  P. Ratcliffe,et al.  Inducible operation of the erythropoietin 3' enhancer in multiple cell lines: evidence for a widespread oxygen-sensing mechanism. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[62]  G. Semenza,et al.  A nuclear factor induced by hypoxia via de novo protein synthesis binds to the human erythropoietin gene enhancer at a site required for transcriptional activation , 1992, Molecular and cellular biology.

[63]  R. Ren,et al.  Poliovirus spreads from muscle to the central nervous system by neural pathways. , 1992, The Journal of infectious diseases.

[64]  A. Mendelow,et al.  Triphenyltetrazolium chloride (TTC) as a marker for ischaemic changes in rat brain following permanent middle cerebral artery occlusion , 1991, Neuropathology and applied neurobiology.

[65]  Wei Hua-sheng.  Severe hand-foot-mouth disease:a report of 3 autopsied cases , 2011 .

[66]  Hilde van der Togt,et al.  Publisher's Note , 2003, J. Netw. Comput. Appl..